ORBIMED ADVISORS LLC 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-27 4:36 pm Sale | 2022-12-22 | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 1,787,569 4.500% | -425,002 (-19.21%) | Filing |
| 2021-08-12 4:17 pm Sale | 2021-08-10 | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,212,571 5.600% | -254,721 (-10.32%) | Filing |